VERAPAMIL HYDROCHLORIDE
- Product NDC
- 70934-584
- 11-digit product format
- 709340584
- Labeler code
- 70934
- Product ID
- 70934-584_abaa89f7-af86-3e7b-e053-2a95a90a6e19
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VERAPAMIL HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA206173
- Marketing category
- ANDA
- Marketing start
- 2020-02-25
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 240 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-584-30 | 70934058430 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-584-30) | 30 tablet | 2020-02-25 | 0000-00-00 | No | No | Current |
| 70934-584-90 | 70934058490 | 90 TABLET in 1 BOTTLE, PLASTIC (70934-584-90) | 90 tablet | 2020-04-24 | 0000-00-00 | No | No | Current |